Serum-Based Quantification of MYCN Gene Amplification in Young Patients with Neuroblastoma: Potential Utility as a Surrogate Biomarker for Neuroblastoma
Fig 2
Kaplan-Meier survival curves for 82 patients and correlation between (a) serum M/N ratio and age of diagnosis and (b) serum M/N ratio and overall survival rate.